Series A - Olatec Therapeutics
Investment Firm
Overview
Olatec is a biopharmaceutical company developing a platform to treat and prevent acute and chronic inflammatory diseases.
Announced Date
Feb 23, 2023
Funding Type
Series A
Highlights
N/A
Location
N/A
Social
N/A
Investor Lead
Participant Investors
2
| Investor Name |
|---|
 Sanders Morris Harris |
Round Details and Background
Olatec Therapeutics raised $40000000 on 2023-02-23 in Series A
Olatec is a biopharmaceutical company developing a platform to treat and prevent acute and chronic inflammatory diseases.
Company Funding History
10
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 29, 2015 | - | 8.8M | ||
| Oct 18, 2018 | - | 15.0M | ||
| Aug 30, 2013 | - | 15.0M | ||
| Aug 01, 2019 | - | 7.5M |
Recent Activity
There is no recent news or activity for this profile.